Uralgic Interactions
There are 753 drugs known to interact with Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate), along with 37 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 255 are major, 483 are moderate, and 15 are minor.
- View all 753 medications that may interact with Uralgic
- View Uralgic alcohol/food interactions (3)
- View Uralgic disease interactions (37)
Most frequently checked interactions
View interaction reports for Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) and the medicines listed below.
- ascorbic acid
- baclofen
- Breo Ellipta (fluticasone / vilanterol)
- cephalexin
- diltiazem
- furosemide
- Hiprex (methenamine)
- lithium
- Lyrica (pregabalin)
- Nexium (esomeprazole)
- omeprazole
- pregabalin
- quetiapine
- tapentadol
- Ventolin (albuterol)
Uralgic alcohol/food interactions
There are 3 alcohol/food interactions with Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
Uralgic disease interactions
There are 37 disease interactions with Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- GI toxicity
- renal dysfunction
- Reye's syndrome
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.